MedPath

understanding the effect periodontal treatment on type 2 diabetes mellitus subjects

Not Applicable
Completed
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2021/06/033985
Lead Sponsor
Haldia Institute of dental sciences and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects with Gingivitis : full mouth bleeding on probing less than 10% of sites.

Subjects with Periodontitis : Subjects with Periodontitis with interdental clinical attachment

loss detectable at >- 2 non adjacent teeth .Buccal or oral clinical attachment loss >-3 mm

with pocketing > 3mm is detectable at >-2 teeth.

Subjects with Periodontally Healthy (PH) : Subjects with PH will have no history of periodontitis, no sites with PD and CAL > 3 mm concurrently and no more than 10% of the sites with gingival bleeding and/or BoP.

Diabetic subjects :The diabetic subjects will require a diagnosis of DM confirmed by a physician, dating from at least 2 years prior to the study. In addition, all diabetic patients will be required to have a HbA1c > 6.5% and FPG > 99 mg/dl.

Non-diabetics: Non-diabetic subjects will have no history of DM, HbA1c = 6.0% and FPG < 99 mg/dl.

Exclusion Criteria

Pregnancy; breastfeeding; subgingival periodontal therapy during the previous 12 months; use of antibiotic, anti-inflammatory, and/or immunosuppressive therapies during the previous 6 months; regular use of mouthrinses containing antimicrobials; use of orthodontic

appliances; presence of other infectious, immunological, and/or inflammatory systemic conditions (e.g., immunological disorders, rheumatoid arthritis) and major complications of DM (i.e.,ulcers, gangrene, amputation, neuropathy, and nephropathy),smokers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in clinical periodontal status, salivary biomakers level and markers of diabetes controlTimepoint: at 3, 6 and 12 months after non surgical periodontal therapy.
Secondary Outcome Measures
NameTimeMethod
Oral health behaviour and Quality of life assessmentTimepoint: 3,6 and 12 months
© Copyright 2025. All Rights Reserved by MedPath